Pinostrobin suppresses Notch signaling and osteogenic differentiation of human aortic valve interstitial cells in vitro
Year: 2026
Type: article
Abstract: Background. Pinostrobin (5-hydroxy-7-methoxyflavanone) is a food bioflavonoid with various pharmacological effects; in the only study available to date, performed on human lung carcinoma cells, a dose-dependent decrease in the expression of Notch signaling components was described under the action of pinostrobin. The Notch signaling pathway plays an important role in the differentiation of interstitial cells of the aortic valve towards the osteogenic line, and its disruption contributes to the development of calcification of the aortic valve, various stages of which are found in at least 26 % of people over 65 years of age. No effective drug therapy for this disease is available, and treatment is only possible surgically, which carries a high risk for patients and places a significant burden on healthcare systems. Objective. The purpose of this study was to investigate the effect of pinostrobin on Notch signaling and on osteogenic differentiation of human aortic valve interstitial cells in vitro. Materials and Methods. Experiments were performed on human aortic valve interstitial cells (VIC) obtained from patients with calcific aortic valve disease and on human umbilical vein endothelial cells (HUVEC). The effect of pinostrobin on the accumulation of calcium deposits during osteogenic differentiation was assessed. The effect of pinostrobin on the expression of Notch target genes was evaluated using quantitative real-time PCR. Notch signaling was modulated with lentiviral constructs carrying the NOTCH1 intracellular domain (NICD) or a short hairpin RNA against CSL/RBPJ (shCSL). α-smooth muscle actin and vimentin were assessed by immunofluorescence staining. Pinostrobin was isolated from the buds of Populus nigra. Results. 10 μM pinostrobin inhibited Notch signaling and suppressed osteogenic differentiation of interstitial aortic valve cells in vitro; cell number decreased by approximately 26 % with no morphological signs of cell death. Under the influence of pinostrobin, RUNX2 expression was reduced by almost half (p < 0.0001), and the intensity of alizarin red staining was reduced 1.5-fold (p = 0.0048) in an osteogenic environment compared to cells not exposed to pinostrobin. Conclusion. Our results suggest that pinostrobin may have the potential to inhibit osteogenic differentiation of aortic valve interstitial cells in vitro and may be a promising candidate for further research.
Source: Translational Medicine
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: pinostrobin, Notch signaling, osteogenic differentiation, aortic valve interstitial cells, calcific aortic valve disease, flavonoids, Runx2, Notch1 intracellular domain, calcium deposition, Populus nigra, aortic valve calcification, therapeutic target, human umbilical vein endothelial cells, cell proliferation inhibition
Open Access status: diamond
OpenAlex ID: W7234097621
